457 related articles for article (PubMed ID: 6222530)
21. Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients.
Rook AH; Smith WJ; Burdick JF; Manischewitz JF; Frederick W; Siegel JP; Williams GM; Quinnan GV
Transplant Proc; 1984 Dec; 16(6):1466-9. PubMed ID: 6095498
[No Abstract] [Full Text] [Related]
22. Humoral and cell-mediated immune responses after donor-specific transfusion (DSBT).
Kovithavongs T; Sharma R; Schlaut J; Burzminski D; Pazderka F; Harley F; Dossetor JB
Transplant Proc; 1989 Feb; 21(1 Pt 2):1822-4. PubMed ID: 2652592
[No Abstract] [Full Text] [Related]
23. The real meaning of changing peripheral blood helper to cytotoxic/suppressor cell ratio during renal allograft rejection.
Kovithavongs T; Dossetor JB
Transplant Proc; 1984 Dec; 16(6):1486-9. PubMed ID: 6239421
[No Abstract] [Full Text] [Related]
24. [Antibody-dependent cell cytotoxicity and spontaneous cytotoxicity of peripheral blood lymphocytes of organ recipients and cells infiltrating the kidney allogeneic transplant].
Drannik GN; Baran EIa; Seniuk OF; Driianskaia VE
Fiziol Zh (1978); 1989; 35(5):68-72. PubMed ID: 2591583
[TBL] [Abstract][Full Text] [Related]
25. The functional dissection of human peripheral null cells with respect to antibody-dependent cellular cytotoxicity and natural killing.
Ozer H; Strelkauskas AJ; Callery RT; Schlossman SF
Eur J Immunol; 1979 Feb; 9(2):112-8. PubMed ID: 312204
[No Abstract] [Full Text] [Related]
26. Suppressor cells inhibiting the generation of cytotoxic T lymphocytes in long-term human transplant recipients.
Thomas J; Johns C; Hoffmann S; Thomas F; Lee HM
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():87-9. PubMed ID: 158755
[No Abstract] [Full Text] [Related]
27. [Evaluation of spontaneous antibody-dependent cellular cytotoxicity (ADCC) and direct spontaneous lymphocyte-mediated cytotoxicity (SLMC) in patients with neoplasms].
Degliantoni G; Mangoni L; Manna A; Fulcini M
G Clin Med; 1981 Sep; 62(9):609-23. PubMed ID: 6976281
[No Abstract] [Full Text] [Related]
28. Targeting and activation of cytotoxic lymphocytes.
Segal DM; Snider DP
Chem Immunol; 1989; 47():179-213. PubMed ID: 2692611
[No Abstract] [Full Text] [Related]
29. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
30. Immunological monitoring of renal allograft recipients using monoclonal antibodies to human T lymphocyte subpopulations.
Ellis TM; Berry CR; Mendez-Picon G; Goldman MH; Lower RR; Lee HM; Mohanakumar T
Transplantation; 1982 Mar; 33(3):317-9. PubMed ID: 6461117
[No Abstract] [Full Text] [Related]
31. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
Langer A; Valdivia LA; Murase N; Woo J; Celli S; Fung JJ; Starzl TE; Demetris AJ
Am J Pathol; 1993 Jul; 143(1):85-98. PubMed ID: 7686346
[TBL] [Abstract][Full Text] [Related]
32. Antibody responses and regulation. A role for natural killer cells.
Robles CP; Pollack SB
Nat Immun Cell Growth Regul; 1986; 5(2):64-74. PubMed ID: 2941681
[No Abstract] [Full Text] [Related]
33. Anti-idiotype antibodies to the 9.1C3 blocking antibody used to probe the lethal hit stage of NK cell-mediated cytolysis.
Werkmeister JA; Burns GF; Triglia T
J Immunol; 1984 Sep; 133(3):1385-90. PubMed ID: 6611373
[TBL] [Abstract][Full Text] [Related]
34. Cell-mediated immunity.
Goust JM
Immunol Ser; 1990; 50():195-215. PubMed ID: 2151118
[No Abstract] [Full Text] [Related]
35. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of allograft rejection.
Hamburger J
Trans Am Soc Artif Intern Organs; 1976; 22():729-33. PubMed ID: 781987
[No Abstract] [Full Text] [Related]
37. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission.
Suzuki M
Jpn J Clin Oncol; 1984 Mar; 14(1):31-40. PubMed ID: 6231391
[TBL] [Abstract][Full Text] [Related]
38. Endothelial-monocyte antigens.
Stastny P
Transplant Proc; 1980 Sep; 12(3 Suppl 1):32-6. PubMed ID: 7001701
[TBL] [Abstract][Full Text] [Related]
39. [Cytotoxic mechanisms involving lymphocytes and cytotoxicity tests].
Nakano K; Tanimoto K
Nihon Rinsho; 1983; 41(4):731-5. PubMed ID: 6193295
[No Abstract] [Full Text] [Related]
40. Non-HLA immunological factors in eighteen HLA-identical renal allografts.
Dossetor JB; Kovithavongs T
Proc Eur Dial Transplant Assoc; 1983; 19():438-44. PubMed ID: 6224209
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
